Antihypertensive drug treatment and fibrinolytic function

American Journal of Hypertension
K LottermoserR Düsing

Abstract

Thromboembolic complications such as ischemic stroke and myocardial infarction are significantly more frequent in patients with arterial hypertension. From the available intervention studies, it appears that pharmacologic treatment of hypertension-at least with diuretics and beta-blockers-may more effectively protect against cerebrovascular as compared to coronary thromboembolic events. Whether other antihypertensive substances provide a more effective protection with respect to cardiac morbidity and mortality is the subject of numerous studies presently underway. These studies will help to answer the question of whether the extent of protection from coronary events during antihypertensive treatment depends on factors beyond blood pressure control. The fibrinolytic system is crucially involved in the pathogenesis of thromboembolic events. One determinant of this system is the balance between plasminogen activators (tissue-type plasminogen activator [t-PA]) and inhibitors (plasminogen activator inhibitor 1 [PAI-1]). Experimental and clinical evidence suggests that at least some of the drugs used in the treatment of hypertension may alter the activity of the fibrinolytic system. Scarce and controversial data with respect to such ...Continue Reading

Citations

Jun 11, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·M Cesari, G P Rossi
Nov 13, 2001·Diabetes, Obesity & Metabolism·D C FelmedenG Beevers
Jun 30, 2005·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Roberto Fogari, Annalisa Zoppi
Jun 2, 2007·The Journal of Clinical Hypertension·Michael M HirschlAnton N Laggner
Dec 28, 2006·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Mervyn D I VergouwenYvo Bwem Roos
Apr 7, 2007·American Journal of Therapeutics·María José Armas-HernándezManuel Valasco
Mar 29, 2008·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Celalettin Usalan, Hakan Buyukhatipoglu
Jul 11, 2009·The Journal of International Medical Research·H BuyukhatipogluC Usalan
Jun 5, 2003·Hypertension·Andrew D BlannGregory Y H Lip
Nov 28, 2012·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Vassiliki GaleaJohn Lekakis
Nov 21, 2002·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·L CoppolaG Gombos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.